Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.03 CAD
Change Today 0.00 / 0.00%
Volume 105.0K
CYX On Other Exchanges
As of 12:57 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

calyx bio-ventures inc (CYX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/31/14 - C$0.10
52 Week Low
12/16/14 - C$0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CALYX BIO-VENTURES INC (CYX)

Related News

No related news articles were found.

calyx bio-ventures inc (CYX) Related Businessweek News

No Related Businessweek News Found

calyx bio-ventures inc (CYX) Details

Calyx Bio-Ventures Inc., an agricultural technology company, focuses on producing renewable diesel and biojet fuels in Canada. The company produces carinata, an energy feedstock crop that provides oil for biofuel production; and seeds to make oil. It also holds a technology license rights to use the ACE System for gene therapy and transgenics. Calyx Bio-Ventures Inc. is headquartered in Vancouver, Canada.

calyx bio-ventures inc (CYX) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

calyx bio-ventures inc (CYX) Key Developments

Calyx Bio-Ventures Inc. Proposes Amendment to Articles

Calyx Bio-Ventures Inc. will propose amendment to Articles to include Advance Notice Provisions at the annual general and special meeting to be held on June 12, 2015.

Calyx Bio-Ventures Inc. Appoints Graeme Watson to Board of Directors

Calyx Bio-Ventures Inc. announced that Graeme Watson has been appointed to the company's Board of Directors. Mr. Watson is a proven business leader with a track record of delivering growth in a profitable manner. Graeme Watson was most recently the President and CEO of Infosat Communications.

Calyx Bio-Ventures Inc., Annual General Meeting, Dec 16, 2014

Calyx Bio-Ventures Inc., Annual General Meeting, Dec 16, 2014., at 14:00 Pacific Standard Time. Location: Suite 2600, Oceanic Plaza. Agenda: To fix the number of directors at three; to elect directors for the ensuing year; to appoint Dale Matheson Carr - Hilton Labonte LLP, as auditor of the company for the ensuing year; to authorize the directors to determine the remuneration to be paid to the auditor; to confirm the company's stock option plan; and to transact such other business as may properly be put before the meeting.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYX:CN C$0.03 CAD 0.00

CYX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CYX.
View Industry Companies

Industry Analysis


Industry Average

Valuation CYX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 5.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CALYX BIO-VENTURES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at